Biotech Startups

Spora is a food research center in Copenhagen that runs and partners in R&D programs combining gastronomy and science to develop new, scalable food products and ingredients from side-streams and alternative sources. It works with industry partners and academia to address food system challenges, serving companies and research institutions in the food innovation space.

1 investor

Spornado develops air sampling and detection equipment for fungal pathogens, serving environmental and industrial clients concerned with contamination monitoring and remediation. The company addresses sustainability through improved detection and management of fungal contamination in indoor and outdoor environments.

1 investor

Sporos Bioventures is a private biotechnology company that uses a portfolio approach to drug development in oncology, holding equity stakes in biopharma entities such as Tvardi Therapeutics and Sporos BioDiscovery. It is based in Houston, Texas.

1 investor

Spotlab develops customized AI models that turn clinical data into biomedical insights, identifying and quantifying digital biomarkers of disease progression and treatment response. Its applications span from blood cancers to neglected tropical diseases, such as detecting helminth eggs in stool samples, serving diagnostics and biopharma research.

1 investor

Sppare.me offers cryopreservation and storage of biological samples, keeping them in liquid-nitrogen tanks at an FDA-registered, state-licensed, CLIA-inspected lab. It operates through a partnership with the Diamond Institute for Infertility and Menopause, a US fertility center.

1 investor

Sprint Bioscience is a pharmaceutical company developing oncology drug candidates aimed at new treatments for hard-to-treat cancers. It uses a fragment-based drug discovery approach and out-licenses its drug programs to global pharmaceutical companies during the preclinical phase.

1 investor

SprouTx is a Japanese company that develops plant-based meat and egg alternatives from sprouted soybeans and peas, designed for food manufacturers and ingredient buyers. The company uses proprietary sprouting technology to create meat-like textures and nutritional profiles suitable for various food applications.

1 investor

Spruce Capital Partners creates, advises, and invests in life sciences companies that make positive environmental impacts and improve human health and wellness.

1 investor

1 investor

ST Pharm is a contract development and manufacturing organization (CDMO) producing active pharmaceutical ingredients, with a focus on gene therapy and nucleic acid technologies spanning oligonucleotides to xRNA.

1 investor

Next-generation universal cell therapy drug development

1 investor

Stable Biologics provides high-throughput formulation development and analytical services for protein-based therapeutics, using self-interaction chromatography (SIC) to screen protein stability and solubility with minimal material. It serves pharmaceutical and biologics developers with end-to-end support spanning protein expression, formulation, analytical testing, stability studies, and Phase I manufacturing.

1 investor

Stablepharma develops a technology platform that converts existing vaccines and biologicals into thermostable, fridge-free products, removing reliance on the refrigerated cold chain. The company targets global health and immunisation applications, aiming to reduce vaccine wastage and the carbon emissions associated with cold-chain storage.

1 investor

Stablix is a preclinical-stage biotechnology company developing small-molecule medicines based on targeted deubiquitination therapeutics (TDT), using heterobifunctional molecules that recruit deubiquitinases (DUBs) to target proteins to restore protein stability and normal function. It focuses on treatments for cancer, rare diseases, and immunological disorders.

1 investor

STADA Arzneimittel AG is a pharmaceutical company based in Germany. No further business details provided on this investor relations contact page.

1 investor

Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics. Its products support blood coagulation and platelet function testing for laboratories, customers, and distributors.

1 investor

Standard Model Biomedicine develops foundation models for medical imaging, language, genomics, and pathology, leveraging expertise from leading pharmaceutical companies and research institutions.

1 investor

1 investor

stane is a mission-driven company that facilitates decentralized clinical research in community/ambulatory medicine, connecting healthcare professionals, study sponsors, and patients through a single platform. It supports pharmaceutical labs, health startups, hospitals, and CROs in designing and running clinical studies in a city/outpatient setting, including regulatory compliance, investigator recruitment, patient consent, and secure health-data management.

1 investor

1 investor

Early-stage clinical company developing Smart Targeted Radioligands for precision oncology of hard-to-heal cancers.

1 investor

STARLIMS offers a laboratory informatics platform combining LIMS, ELN, SDMS, LES, and advanced analytics software for R&D, quality control, and manufacturing teams to accelerate product development and automate lab workflows. The platform serves pharmaceutical, biotech, and manufacturing organizations managing complex lab operations and compliance requirements.

1 investor

Starna Therapeutics develops RNA-based therapeutic drugs focused on hepatic and extrahepatic targeted delivery technology. The company has built a proprietary platform of cationic lipids and lipid nanoparticles (LNPs) to achieve organ-specific delivery and is advancing clinical-stage mRNA vaccine and mRNA therapeutic candidates.

1 investor

The START Center for Cancer Research is a community-based early phase oncology research organization that runs clinical trials across a network of specialized units, having contributed to over 50 FDA/EMA-approved cancer therapies. It operates 15 research locations across the United States and Europe, working with community oncology centers, biopharma sponsors, and CROs.

1 investor